Flonase and Pegintron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flonase (fluticasone propionate) and Pegintron (peginterferon alfa-2b). Common drug interactions include fatigue among females and dysgeusia among males.

The phase IV clinical study analyzes what interactions people have when they take Flonase and Pegintron. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Pegintron?

Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,326 Pegintron users. Check the latest studies of Pegintron.

On Jul, 13, 2026

11 people who take Flonase and Pegintron together, and have interactions are studied.

Flonase and Pegintron drug interactions.

What are the common drug interactions of Flonase and Pegintron, by gender? *:

female:

Fatigue (feeling of tiredness)
Red blood cell count decreased
Erythema (redness of the skin)
Influenza like illness
Injection site rash
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nausea (feeling of having an urge to vomit)
Pain in extremity

male:

Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Dry mouth
Dyspepsia (indigestion)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Haemorrhage (bleeding)
Influenza like illness
Injection site irritation
Injection site rash

What are the common drug interactions of Flonase and Pegintron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Feeling hot
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Pain
Pharyngeal disorder

30-39:

n/a

40-49:

Red blood cell count decreased
Fatigue (feeling of tiredness)
Injection site rash

50-59:

Fatigue (feeling of tiredness)
Dysgeusia (disorder of the sense of taste)
Dry mouth
Dyspepsia (indigestion)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Haemorrhage (bleeding)
Injection site irritation
Injection site rash
Mouth ulceration (mouth ulcers)

60+:

n/a

What are the existing conditions these people have? *

Night Sweats (sweating in night): 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Hot Flush (sudden feelings of heat): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%
Depression: 1 person, 9.09%
Cough: 1 person, 9.09%
Anaemia (lack of blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and Pegintron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously